EW
$86.96
Revenue | $1534.1Mn |
Net Profits | $369.9Mn |
Net Profit Margins | 24.11% |
Edwards Lifesciences Corp.’s revenue jumped 13.78% since last year same period to $1534.1Mn in the Q4 2023. On a quarterly growth basis, Edwards Lifesciences Corp. has generated 3.59% jump in its revenue since last 3-months.
Edwards Lifesciences Corp.’s net profit fell -7.15% since last year same period to $369.9Mn in the Q4 2023. On a quarterly growth basis, Edwards Lifesciences Corp. has generated -3.9% fall in its net profits since last 3-months.
Edwards Lifesciences Corp.’s net profit margin fell -18.4% since last year same period to 24.11% in the Q4 2023. On a quarterly growth basis, Edwards Lifesciences Corp. has generated -7.23% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.64 |
EPS Estimate Current Year | 0.64 |
Edwards Lifesciences Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.64 - a 0% jump from last quarter’s estimates.
Edwards Lifesciences Corp.’s earning per share (EPS) estimates for the current year stand at 0.64.
Earning Per Share (EPS) | 0.64 |
Edwards Lifesciences Corp.’s earning per share (EPS) jumped 0% since last year same period to 0.64 in the Q4 2023. This indicates that the Edwards Lifesciences Corp. has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-07-28 | 0.65 | 0.66 | 1.54% |
2023-04-28 | 0.61 | 0.62 | 1.64% |
2023-10-27 | 0.59 | 0.59 | 0% |
2024-02-12 | 0.64 | 0.64 | 0% |